Gowardhan Biochem Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.50 Cr
as on 17-11-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.10 Cr
as on 17-11-2024
- Satisfied Charges ₹ 4.00 Cr
as on 17-11-2024
- Revenue 290.91%
(FY 2023)
- Profit 627.48%
(FY 2023)
- Ebitda 9288.41%
(FY 2023)
- Net Worth 24.98%
(FY 2023)
- Total Assets 16.23%
(FY 2023)
About Gowardhan Biochem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹7.10 Cr. The company has closed loans amounting to ₹4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Achal Bansal, Akash Bansal, and Binod Bansal serve as directors at the Company.
- CIN/LLPIN
U15400CT2019PTC009299
- Company No.
009299
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Durg, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gowardhan Biochem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Achal Bansal  | Whole-Time Director | 28-May-2019 | Current |
| Akash Bansal | Director | 28-May-2019 | Current |
| Binod Bansal | Director | 31-Jul-2021 | Current |
Financial Performance of Gowardhan Biochem.
Gowardhan Biochem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 290.91% increase. The company also saw a substantial improvement in profitability, with a 627.48% increase in profit. The company's net worth Soared by an impressive increase of 24.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gowardhan Biochem?
In 2023, Gowardhan Biochem had a public holding of 16.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Sep 2024 | ₹2.50 M | Open |
Others Creation Date: 28 Feb 2022 | ₹1.90 Cr | Open |
Others Creation Date: 28 Feb 2022 | ₹4.95 Cr | Open |
How Many Employees Work at Gowardhan Biochem?
Unlock and access historical data on people associated with Gowardhan Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gowardhan Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gowardhan Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
